By Dameka Williams, Chief Research & Insights Officer, Science and Medicine Group For decades, diagnostic imaging manufacturers have anchored their growth strategies to clinical demand, capital cycles, and incremental modality innovation. However, a quieter (and potentially more disruptive) shift is now underway upstream in the life sciences. While often discussed in the context of toxicology […]
The U.S. diagnostic imaging market is valued at approximately $150 billion in 2025 and encompasses an estimated 600 million or more procedures annually. But where a scan is performed matters enormously — for the patient’s bill, the provider’s bottom line, and the trajectory of healthcare spending. Diagnostic imaging is delivered across four distinct facility types: […]
The diagnostic imaging industry is continuing to see significant technological innovation. Across CT, MRI, and ultrasound, OEMs are bringing innovations to market that don’t just improve image quality — they have the potential to change where, how, and by whom imaging is performed. Three key forces driving this transformation are: the pursuit of higher diagnostic […]
From 2020 to 2023, the number of general x-ray procedures performed in main hospital radiology departments declined 16%, from 88.7 million in 2020, to 74.5 million in 2023 for an overall annualized rate of decline of 4.3%, according to the newly published “IMV 2024 Diagnostic X-Ray Market Outlook Report.” By site type, over the same period, […]
In the dynamic diagnostic imaging industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]